Welcome to the STING & TLR-Targeting Therapies Summit
Plus Innate Immune Checkpoints & Activation Pre-Conference Focus Day
The STING & TLR-Targeting Therapies Summit is coming at a timely inflection point in this field.
With multiple TLR agonists moving into the clinic, STING agonists exposing new challenges, multiple approvals on the horizon, and more novel targets and combinations currently undergoing exciting pre-clinical validation than ever before, this unique and highly anticipated industry-focused meeting will unite experts in innate immunity to overcome the barriers it faces and accelerate clinical breakthrough.
Returning digitally in 2022, 30+ expert speakers will take you through case-study led presentations, juicy panel discussions and live Q&A’s, all tailored to suit your TLR, STING & other PRR targeting needs.
This is the key in-person biopharma conference for research teams
developing drug candidates targeting any specific PRR targets (TLRs,
cGAS/STING, NLRs, CLRs, RLRs) to revolutionize treatment options for patients.
If you are striving to create best-in-class innate immunity
therapeutics, don’t miss this unique and highly anticipated industry-focused meeting uniting world-experts in innate immunity to propel this space through the barriers it faces to clinical breakthrough.
View the event guide now for the full agenda.
2022 Speakers Included:
Chief Scientific Officer
Assistant Professor of Medicine
UMass Chan Medical School Department of Medicine
Senior Director & Head of Project Leader Group, Innate Immunity Research Unit & Senior Fellow
What Will You Learn?
Clinical progress with innate immune-targeting compounds
Rationale & progress in targeting different TLRs
The development of predictive preclinical models in PRR research to achieve human-specific translation
The emerging targets in PRR-targeting: strategy, execution, development & promise
How to optimize clinical trial design for innate immunotherapy drug development
How to optimize your PRR-based drug delivery technology
How to analyze & optimize the various drug format options
The next steps in PRR combination interventions to heighten drug effect & overcome resistance - is this the future?
Innate Immune Checkpoints & Activation Pre-Focus Day
The dedicated focus day will delve into identifying the role of innate subsets during checkpoint blockade to develop combination therapies and help overcome checkpoint resistance through:
- Delving into honing of innate cells
- Nw methodologies of analyzing innate immune cells in the tumor microenvironment
- Exploring reprograming of the tumor micoenvironment
- Optimizing in vitro models and discovery technologies for innate cell-based therapies
- Uncovering novel checkpoint inhibitors
- Gaining updates on
clinical trials for
Who Joined in 2022?
Proud to Partner With:
The health, safety and well-being of our community remains our highest priority. Therefore, all attendees will be required to complete a health declaration prior to attending the event. As part of this, attendees must declare that they are either fully vaccinated and /or have completed a negative Lateral Flow Test or PCR Test within 48 hours the event*. For further information around Health and Safety onsite, please visit our FAQ here.
*Please note, this is subject to change at any time without prior notice.